Biosciences
- REVIEWS
Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation?
On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf. These are creatures…
Read More » - APPLICATIONS
Why Most Microsegmentation Projects Fail—And How Andelyn Biosciences Got It Right
Most microsegmentation projects fail before they even get off the ground—too complex, too slow, too disruptive. But Andelyn Biosciences proved…
Read More »
